ATHE logo

ATHE Depreciation And Amortization

Annual D&A

$96.70 K
+$27.90 K+40.55%

June 1, 2024

Summary

Performance

1-Year Change

+40.55%

3-Year Change

+71.76%

5-Year Change

+356.13%

15-Year Change

+500.62%

ATHE Depreciation And Amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

12.12%
ATHE annual depreciation & amortization is higher than 12.12% of companies in Healthcare sector

High & Low

All-time High

$847.60 K
ATHE annual depreciation & amortization is currently -88.59% below its historical high of $847.60 thousand

3-Year Low

$39.30 K
ATHE annual depreciation & amortization is currently +146.06% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Jun 1, 2024
ATHE previous annual earnings announcement was published on Jun 1, 2024

Next Annual Earnings Report Date

N/A
ATHE next annual earnings announcement has not yet been scheduled

Related metrics

Annual Total Expenses

$12.71 M
ATHE annual total expenses is $12.71 million

Annual Operating Expenses

$12.71 M
ATHE annual total operating expenses is $12.71 million

Annual Cost Of Goods Sold

-
ATHE annual cost of goods sold value is unknown

Annual Interest Expense

-
ATHE annual interest expense value is unknown

Quarterly D&A

N/A

June 1, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

ATHE Quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$68.80 K
ATHE quarterly depreciation & amortization is currently at an all-time high

3-Year Low

$23.00 K
ATHE quarterly depreciation & amortization is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 1, 2024
ATHE previous earnings announcement was published on Jun 1, 2024

Next Quarterly Earnings Report Date

N/A
ATHE next earnings announcement has not yet been scheduled

Related metrics

Quarterly Total Expenses

-
ATHE quarterly total expenses value is unknown

Quarterly Operating Expenses

-
ATHE quarterly total operating expenses value is unknown

Quarterly Cost Of Goods Sold

-
ATHE quarterly cost of goods sold value is unknown

Quarterly Interest Expense

-
ATHE quarterly interest expense value is unknown

TTM D&A

N/A

June 1, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

ATHE TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$101.70 K
ATHE TTM depreciation & amortization is currently at an all-time high

3-Year Low

$23.00 K
ATHE TTM depreciation & amortization is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 1, 2024
ATHE previous earnings announcement was published on Jun 1, 2024

Next Quarterly Earnings Report Date

N/A
ATHE next earnings announcement has not yet been scheduled

Related metrics

Annual Total Expenses

$12.71 M
ATHE annual total expenses is $12.71 million

Annual Operating Expenses

$12.71 M
ATHE annual total operating expenses is $12.71 million

TTM Cost Of Goods Sold

-
ATHE TTM cost of goods sold value is unknown

TTM Interest Expense

-
ATHE TTM interest expense value is unknown

ATHE Depreciation And Amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+40.5%--
3 y3 years+71.8%--
5 y5 years+356.1%--

ATHE Depreciation And Amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+146.1%
5 y5-yearat high+356.1%
alltimeall time-88.6%+500.6%

Alterity Therapeutics Limited Depreciation And Amortization History

DateAnnualQuarterlyTTM
Jun 2024
$96.70 K(+40.6%)
-
-
Jun 2023
$68.80 K(+75.1%)
$68.80 K(+109.1%)
$101.70 K(+40.9%)
Dec 2022
-
$32.90 K(-16.3%)
$72.20 K(+15.9%)
Jun 2022
$39.30 K(-30.2%)
$39.30 K(+70.9%)
$62.30 K(+170.9%)
Dec 2021
-
$23.00 K(-41.2%)
$23.00 K(-41.2%)
Jun 2021
$56.30 K(-25.4%)
-
-
Jun 2020
$75.50 K(+256.1%)
-
-
Dec 2019
-
$39.10 K(+311.6%)
$39.10 K(+311.6%)
Jun 2019
$21.20 K(+25.4%)
-
-
Jun 2018
$16.90 K(+5.0%)
-
-
Jun 2017
$16.10 K(-3.0%)
-
-
Jun 2016
$16.60 K(-37.1%)
-
-
Dec 2015
-
$9500.00
$9500.00
DateAnnualQuarterlyTTM
Jun 2015
$26.40 K(+28.8%)
-
-
Jun 2014
$20.50 K(-13.9%)
-
-
Jun 2013
$23.80 K(+17.8%)
-
-
Jun 2012
$20.20 K(-35.0%)
-
-
Jun 2011
$31.10 K(0.0%)
-
-
Jun 2010
$31.10 K(+22.0%)
-
-
Jun 2009
$25.50 K(+12.3%)
-
-
Jun 2008
$22.70 K(-50.7%)
-
-
Jun 2007
$46.00 K(-48.0%)
-
-
Jun 2006
$88.40 K(-20.6%)
-
-
Jun 2005
$111.30 K(-86.9%)
-
-
Jun 2004
$847.60 K(+22.6%)
-
-
Jun 2003
$691.10 K(+13.7%)
-
-
Jun 2002
$608.00 K
-
-

FAQ

  • What is Alterity Therapeutics Limited annual depreciation & amortization?
  • What is the all time high annual D&A for Alterity Therapeutics Limited?
  • What is Alterity Therapeutics Limited annual D&A year-on-year change?
  • What is the all time high quarterly D&A for Alterity Therapeutics Limited?
  • What is the all time high TTM D&A for Alterity Therapeutics Limited?

What is Alterity Therapeutics Limited annual depreciation & amortization?

The current annual D&A of ATHE is $96.70 K

What is the all time high annual D&A for Alterity Therapeutics Limited?

Alterity Therapeutics Limited all-time high annual depreciation & amortization is $847.60 K

What is Alterity Therapeutics Limited annual D&A year-on-year change?

Over the past year, ATHE annual depreciation & amortization has changed by +$27.90 K (+40.55%)

What is the all time high quarterly D&A for Alterity Therapeutics Limited?

Alterity Therapeutics Limited all-time high quarterly depreciation & amortization is $68.80 K

What is the all time high TTM D&A for Alterity Therapeutics Limited?

Alterity Therapeutics Limited all-time high TTM depreciation & amortization is $101.70 K